JP2022540089A5 - - Google Patents
Info
- Publication number
- JP2022540089A5 JP2022540089A5 JP2022500558A JP2022500558A JP2022540089A5 JP 2022540089 A5 JP2022540089 A5 JP 2022540089A5 JP 2022500558 A JP2022500558 A JP 2022500558A JP 2022500558 A JP2022500558 A JP 2022500558A JP 2022540089 A5 JP2022540089 A5 JP 2022540089A5
- Authority
- JP
- Japan
- Prior art keywords
- contain
- protein complex
- ttr
- complex according
- ttr protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962871247P | 2019-07-08 | 2019-07-08 | |
| US62/871,247 | 2019-07-08 | ||
| PCT/US2020/040873 WO2021007150A1 (en) | 2019-07-08 | 2020-07-06 | Multispecific transthyretin immunoglobulin fusions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022540089A JP2022540089A (ja) | 2022-09-14 |
| JP2022540089A5 true JP2022540089A5 (https=) | 2023-06-22 |
| JP7695925B2 JP7695925B2 (ja) | 2025-06-19 |
Family
ID=71784719
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022500558A Active JP7695925B2 (ja) | 2019-07-08 | 2020-07-06 | 多特異性トランスサイレチン免疫グロブリン融合物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220324924A1 (https=) |
| EP (1) | EP3997112A1 (https=) |
| JP (1) | JP7695925B2 (https=) |
| KR (1) | KR20220032065A (https=) |
| CN (1) | CN114127125B (https=) |
| AU (1) | AU2020310851B2 (https=) |
| CA (1) | CA3140208A1 (https=) |
| MX (1) | MX2021015976A (https=) |
| SG (1) | SG11202112762TA (https=) |
| WO (1) | WO2021007150A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3692061A1 (en) | 2017-10-04 | 2020-08-12 | Amgen Inc. | Transthyretin immunoglobulin fusions |
| EP4234695A1 (en) * | 2022-02-24 | 2023-08-30 | Sartorius BIA Separations d.o.o. | Methods for the selective removal of contaminants during a process of purifying biologic agents |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4447A (en) | 1846-04-04 | Car- wheel | ||
| US233A (en) | 1837-06-14 | Improvement in plows | ||
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| US4263428A (en) | 1978-03-24 | 1981-04-21 | The Regents Of The University Of California | Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same |
| IE52535B1 (en) | 1981-02-16 | 1987-12-09 | Ici Plc | Continuous release pharmaceutical compositions |
| US4475196A (en) | 1981-03-06 | 1984-10-02 | Zor Clair G | Instrument for locating faults in aircraft passenger reading light and attendant call control system |
| DE3374837D1 (en) | 1982-02-17 | 1988-01-21 | Ciba Geigy Ag | Lipids in the aqueous phase |
| US4439196A (en) | 1982-03-18 | 1984-03-27 | Merck & Co., Inc. | Osmotic drug delivery system |
| US4447224A (en) | 1982-09-20 | 1984-05-08 | Infusaid Corporation | Variable flow implantable infusion apparatus |
| US4487603A (en) | 1982-11-26 | 1984-12-11 | Cordis Corporation | Implantable microinfusion pump system |
| US4486194A (en) | 1983-06-08 | 1984-12-04 | James Ferrara | Therapeutic device for administering medicaments through the skin |
| HUT35524A (en) | 1983-08-02 | 1985-07-29 | Hoechst Ag | Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance |
| DE3474511D1 (en) | 1983-11-01 | 1988-11-17 | Terumo Corp | Pharmaceutical composition containing urokinase |
| US4596556A (en) | 1985-03-25 | 1986-06-24 | Bioject, Inc. | Hypodermic injection apparatus |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US5260203A (en) | 1986-09-02 | 1993-11-09 | Enzon, Inc. | Single polypeptide chain binding molecules |
| EP0281604B1 (en) | 1986-09-02 | 1993-03-31 | Enzon Labs Inc. | Single polypeptide chain binding molecules |
| US4941880A (en) | 1987-06-19 | 1990-07-17 | Bioject, Inc. | Pre-filled ampule and non-invasive hypodermic injection device assembly |
| US4790824A (en) | 1987-06-19 | 1988-12-13 | Bioject, Inc. | Non-invasive hypodermic injection device |
| US5064413A (en) | 1989-11-09 | 1991-11-12 | Bioject, Inc. | Needleless hypodermic injection device |
| US5312335A (en) | 1989-11-09 | 1994-05-17 | Bioject Inc. | Needleless hypodermic injection device |
| US5383851A (en) | 1992-07-24 | 1995-01-24 | Bioject Inc. | Needleless hypodermic injection device |
| US20030191056A1 (en) | 2002-04-04 | 2003-10-09 | Kenneth Walker | Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins |
| BRPI0611901A2 (pt) | 2005-06-14 | 2012-08-28 | Amgen, Inc | composição, liofilizado, kit, e, processo para preparar uma composição |
| MY192182A (en) | 2009-06-26 | 2022-08-04 | Regeneron Pharma | Readily isolated bispecific antibodies with native immunoglobulin format |
| WO2013180295A1 (ja) | 2012-06-01 | 2013-12-05 | 日本電信電話株式会社 | パケット転送処理方法およびパケット転送処理装置 |
| US9580486B2 (en) | 2013-03-14 | 2017-02-28 | Amgen Inc. | Interleukin-2 muteins for the expansion of T-regulatory cells |
| KR20250057056A (ko) * | 2013-12-20 | 2025-04-28 | 뉴리뮨 홀딩 아게 | 트랜스티레틴(ttr) 아밀로이드증의 항체-기반의 치료 및 이를 위한 인간-유래의 항체 |
| US9300829B2 (en) | 2014-04-04 | 2016-03-29 | Canon Kabushiki Kaisha | Image reading apparatus and correction method thereof |
| TWI769570B (zh) * | 2015-01-28 | 2022-07-01 | 愛爾蘭商普羅佘納生物科技有限公司 | 抗甲狀腺素運送蛋白抗體 |
| WO2017083604A1 (en) | 2015-11-12 | 2017-05-18 | Amgen Inc. | Triazine mediated pharmacokinetic enhancement of therapeutics |
| EP3692061A1 (en) * | 2017-10-04 | 2020-08-12 | Amgen Inc. | Transthyretin immunoglobulin fusions |
-
2020
- 2020-07-06 EP EP20745438.0A patent/EP3997112A1/en active Pending
- 2020-07-06 MX MX2021015976A patent/MX2021015976A/es unknown
- 2020-07-06 CN CN202080049750.1A patent/CN114127125B/zh active Active
- 2020-07-06 US US17/624,824 patent/US20220324924A1/en active Pending
- 2020-07-06 KR KR1020227003259A patent/KR20220032065A/ko active Pending
- 2020-07-06 AU AU2020310851A patent/AU2020310851B2/en active Active
- 2020-07-06 JP JP2022500558A patent/JP7695925B2/ja active Active
- 2020-07-06 SG SG11202112762TA patent/SG11202112762TA/en unknown
- 2020-07-06 CA CA3140208A patent/CA3140208A1/en active Pending
- 2020-07-06 WO PCT/US2020/040873 patent/WO2021007150A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6841596B2 (ja) | 改変されたヘルパーファージを用いて抗原結合分子を作製する方法 | |
| JP6781740B2 (ja) | ヘテロ二量体のＩｇＧ様分子を生産する方法、ヘテロ二量体のＩｇＧ様分子、ヘテロ二量体の抗体、組み換え宿主細胞、医薬組成物、宿主細胞を作成する方法、および培養物 | |
| CN102239182B (zh) | Muc1*抗体 | |
| JP2023058590A5 (https=) | ||
| CN106967172A (zh) | 抗ctla4‑抗pd‑1 双功能抗体、其药物组合物及其用途 | |
| JP6143133B2 (ja) | ヒト化抗ヒト上皮成長因子受容体抗体、そのコード遺伝子及びその応用 | |
| JP2022513326A5 (https=) | ||
| CN115057936A (zh) | 异源二聚体多特异性抗体形式 | |
| KR20160021196A (ko) | 안정화된 가용성 예비융합 ｒｓｖ ｆ 폴리펩타이드 | |
| CA2892623A1 (en) | Ch3 domain variant pair inducing formation of heterodimer of heavy chain constant region of antibody at high efficiency, method for preparing same, and use thereof | |
| CN112480239B (zh) | 人乳头瘤病毒特异性t细胞受体及其抗肿瘤用途 | |
| CN105229036A (zh) | 在疏水性相互作用位点内引入了静电相互作用的蛋白及其制备方法 | |
| JP2022541761A5 (https=) | ||
| JP2022540089A5 (https=) | ||
| JP2014534807A (ja) | クロスプレゼンテーションを行う樹状細胞を標的としたワクチボディ | |
| CN113968910A (zh) | 四价对称双特异性抗体 | |
| JP2024507693A (ja) | 二重特異性抗体 | |
| JP2025137512A (ja) | 新規に設計された共局在化依存性タンパク質スイッチを使用する超特異的細胞標的化 | |
| JP2021506310A5 (https=) | ||
| TW201904998A (zh) | 不對稱異二聚fc-scfv融合抗globo h及抗cd3雙特異性抗體及其於癌症治療上之用途 | |
| JPWO2020071554A5 (https=) | ||
| JP2023550191A (ja) | Ｄｒ４および／またはｄｒ５を標的とするポリペプチドならびに関連する組成物および方法 | |
| CN114163504A (zh) | SARS-CoV-2 S蛋白RBD区中和表位肽及其应用 | |
| JP6975716B2 (ja) | 樹状細胞標的化ペプチド、当該ペプチドを利用したペプチド融合体、及び当該ペプチド融合体を利用したワクチン | |
| CN117402237A (zh) | 一种抗新型冠状病毒的双特异性抗体及其应用 |